India to United States: Methotrexate Export Trade Route
India has recorded 96 verified shipments of Methotrexate exported to United States, representing a combined trade value of $4.5M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $47.1K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 51% of total export value with 35 shipments worth $2.3M USD. On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer in United States with $778.5K USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together control 84% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Methotrexate corridor is one of India's established pharmaceutical export routes, with 96 shipments documented worth a combined $4.5M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's methotrexate manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $47.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with methotrexate's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 18.7%, placing it at rank #19 among India's top methotrexate export destinations globally.
On the import side, key buyers of Indian methotrexate in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, J. KNIPPER & COMPANY and 20 others. AUROBINDO PHARMA USA., INC, is the single largest importer with 18 shipments valued at $778.5K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#19
- Annual growth+18.7%
- Demand growth+16.0%
- Regulatory ease80/100
Top 10 Indian Methotrexate Exporters to United States
Showing top 10 of 14 Indian suppliers exporting Methotrexate to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $66.0K per shipment | 35 | $2.3M | 51.1% |
| 2 | ZYDUS LIFESCIENCES LIMITED Avg $96.1K per shipment | 8 | $768.5K | 17.0% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED Avg $92.2K per shipment | 8 | $737.9K | 16.3% |
| 4 | CADILA HEALTHCARE LIMITED Avg $117.1K per shipment | 4 | $468.2K | 10.4% |
| 5 | CADILA HEALTHCARE LTD Avg $225.1K per shipment | 1 | $225.1K | 5.0% |
| 6 | ATLAS ENTERPRISES Avg $356 per shipment | 16 | $5.7K | 0.1% |
| 7 | DELON INC. Avg $1.5K per shipment | 1 | $1.5K | 0.0% |
| 8 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $369 per shipment | 4 | $1.5K | 0.0% |
| 9 | VEA IMPEX (I) PRIVATE LIMITED Avg $185 per shipment | 7 | $1.3K | 0.0% |
| 10 | VEA IMPEX I PRIVATE LIMITED Avg $242 per shipment | 2 | $483 | 0.0% |
This table shows the top 10 of 14 Indian companies exporting methotrexate to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, ATLAS ENTERPRISES, DELON INC., MYGENIC HEALTHCARE PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX I PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 35 shipments worth $2.3M USD, giving it a 51% market share. The top 3 suppliers together account for 84% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to United States Methotrexate export route.
Top 10 Methotrexate Importers in United States
Showing top 10 of 23 known buyers in United States receiving Methotrexate shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian methotrexate in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, J. KNIPPER & COMPANY, ZYDUS PHARMACEUTICALS USA INC, AUROBINDO PHARMA USA INC, among 23 total buyers. The largest importer is AUROBINDO PHARMA USA., INC,, accounting for $778.5K USD across 18 shipments — representing 17% of all methotrexate imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA., INC, | 18 | $778.5K | 17.2% |
| 2 | XXDUSXXHARXXCEUXXCALXXUSAXXNC | 8 | $768.5K | 17.0% |
| 3 | J. KNIPPER & COMPANY | 8 | $737.9K | 16.3% |
| 4 | ZYDUS PHARMACEUTICALS USA INC | 5 | $693.4K | 15.3% |
| 5 | AUROBINDO PHARMA USA INC | 6 | $666.8K | 14.7% |
| 6 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 5 | $299.8K | 6.6% |
| 7 | AUROBINDO PHARMA USA. INC | 2 | $236.3K | 5.2% |
| 8 | AUROLOGISTICS LLC AUROBINDO PHARM | 2 | $207.9K | 4.6% |
| 9 | AUROLOGISTICS LLC (AUROBINDO PHARM | 2 | $121.0K | 2.7% |
| 10 | VERONICA HERNANDEZ | 7 | $4.7K | 0.1% |
Showing top 10 of 23 Methotrexate importers in United States on this route.
Top 10 Methotrexate Formulations Imported by United States
Showing top 10 of 62 product formulations shipped on the India to United States Methotrexate route, ranked by trade value
United States imports a wide range of methotrexate formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — METHOTREXATE TABLETS USP 2.5 MG 100'S - — accounts for $1.2M USD across 9 shipments. There are 62 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | METHOTREXATE TABLETS USP 2.5 MG 100'S - | 9 | $1.2M | 25.7% |
| 2 | METHOTREXATE TABLETS USP 2.5 MG - | 3 | $223.5K | 4.9% |
| 3 | METHOTREXATE TABLETS 2.5 MG (METHOTREXAT | 1 | $162.9K | 3.6% |
| 4 | METHOTREXATE TABLETS USP 2.5 MG (METHOTREXATE TABLETS USP 2.5MG_100'S _APUS (39576X100'S) | 1 | $146.0K | 3.2% |
| 5 | METHOTREXATE TABLETS 2.5 MG 35458X100'S | 1 | $145.5K | 3.2% |
| 6 | METHOTREXATE TABLETS 2.5 MG METHOTREXATE TABLETS 2.5MG 100 S HDPE PACKING STAGE FOR USA QTY: 35214 PACKS | 1 | $142.6K | 3.2% |
| 7 | METHOTREXATE TABLETS 2.5 MG METHOTREXATE TABLETS 2.5 MG 100 S HDPE PACKING STAGE FOR USA QTY: 35613 PACKS | 1 | $140.7K | 3.1% |
| 8 | METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5 MG (100 S HDPE PACKING STAGE FOR USA)) (QTY: 35419 PACKS) | 1 | $140.3K | 3.1% |
| 9 | METHOTREXATE TABLETS 2.5 MG (METHOTREXATE TABLETS 2.5 MG) (35491X100'S) | 1 | $125.8K | 2.8% |
| 10 | METHOTREXATE TABLETS USP 2.5 MG (METHOTREXATE TABLETS USP 2.5MG_100'S _APUS (33252X100'S) | 1 | $122.6K | 2.7% |
Showing top 10 of 62 Methotrexate formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 23 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's methotrexate exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 35 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together account for 84% of total trade value on this route. The average shipment value of $47.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as methotrexate tablets usp 2.5 mg - and methotrexate tablets 2.5 mg (methotrexat, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer with 18 shipments worth $778.5K USD — representing 17% of all methotrexate imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.5M
- Avg. Shipment
- $47.1K
- Suppliers
- 14
- Buyers
- 23
- Transit (Sea)
- ~17 days
- Annual Growth
- +18.7%
Related Analysis
Reverse Direction
United States → India — Methotrexate (Import)Other Methotrexate Routes
Unlock the Full India to United States Methotrexate Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 96 shipments on this route.
Frequently Asked Questions — India to United States Methotrexate Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Methotrexate to United States?
The leading Indian exporters of Methotrexate to United States are EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS LIFESCIENCES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 51% of total trade value on this route.
Q What is the total value of Methotrexate exports from India to United States?
India exports Methotrexate to United States worth approximately $4.5M USD across 96 recorded shipments. The average value per shipment is $47.1K USD.
Q Which ports does India use to ship Methotrexate to United States?
The most active port of origin is SAHAR AIR with 23 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to United States for Methotrexate?
The average transit time for Methotrexate shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Methotrexate trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.7% with demand growth tracking at 16.0%. The route is ranked #19 among India's top Methotrexate export destinations globally.
Q How many suppliers are active on the India to United States Methotrexate route?
There are currently 14 active Indian suppliers exporting Methotrexate to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 51% of total shipment value.
Q Who are the main importers of Methotrexate from India in United States?
The leading importers of Indian Methotrexate in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, J. KNIPPER & COMPANY, ZYDUS PHARMACEUTICALS USA INC, AUROBINDO PHARMA USA INC. AUROBINDO PHARMA USA., INC, is the largest buyer with 18 shipments worth $778.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Methotrexate.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 23 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 96 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
96 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists